NCT01904903: A trial that was reported late by Medstar Health Research Institute
This trial has reported, although it was 73 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT01904903 |
|---|---|
| Title | SAFE-HEaRt: A Pilot Study Assessing the Cardiac SAFEty of HER2 Targeted Therapy in Patients With HER2 Positive Breast Cancer and Reduced Left Ventricular Function |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Oct. 31, 2013 |
| Completion date | June 30, 2019 |
| Required reporting date | June 29, 2020, midnight |
| Actual reporting date | Sept. 11, 2020 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | 73 |